TimeTech M&A Evaluation, Integration and Restructuring Gateways

Strategic-level simulation · From multi-method valuation and due diligence through to deal structuring, financing, synergy validation and exit governance

Level：Strategic Duration：about 120 min Points available：16 Agent roles：7

As M&A project manager, you lead TimeTech's non-binding acquisition evaluation of HealthCare Ltd. — reconciling three preliminary valuations, running financial, legal, commercial, data, technical-service and people due diligence, designing deal and financing terms, testing synergies and liquidity, and shaping Day 1 / 100-day integration alongside pause, alliance, minority-investment, asset-deal, restructuring or exit options.

Start learning

The question

In 2026 TimeTech reported sales revenue of $55 million, net profit of $9 million and cash reserves of $25 million. Cash reserves do not equate to funds available for this project.

Company background

TimeTech Ltd. develops, manufactures and sells smart wearable devices and provides online health-management services. The company is authorised only to carry out a non-binding acquisition evaluation of HealthCare Ltd.; HealthCare has not yet been acquired, and no payment or irreversible commitment has been approved. ChipDesign Ltd. features only as an alternative scenario for a technology-driven acquisition or backward integration.

Techniques

事实、估值与证据边界尽职调查与风险诊断交易结构、融资与谈判整合、协同与重组治理取证与董事会沟通

Who it suits

Recommended for learners who already grasp the fundamentals of F3 business valuation, acquisition financing and restructuring and are preparing for the Strategic level , focusing on evidence boundaries, deal design, integration governance and board-level communication.

All courses

Home